Statins and noncardiac vascular disease
Current Opinion in Cardiology, 06/27/2012
Paraskevas KI et al. – Routine statin treatment should be implemented for all vascular patients to ensure a reduced progression of their disease, as well as a reduction in cardiovascular events.Results
- Evidence suggests that statins may reduce the progression (or even reverse the development) of carotid artery stenosis and AAAs.
- Statins also improve several indices (e.g. serum creatinine) and preserve renal function in ARAS.
- In patients with PAD, statins are associated with improved claudication distance and time, reduced cardiovascular events, and improved graft patency rates should these patients undergo surgery.
- Finally, statins are associated with improved perioperative and long–term morbidity and mortality rates in all vascular patients whether they undergo surgery or endovascular procedures.